๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Immunoglobulin A Nephropathy
Clinical trial register · Spain

Immunoglobulin A Nephropathy Trials in Spain, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 5885 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:52 UTC
5885
Studies in scope
all four open statuses
3103
Recruiting now
open to new participants
1139
Lead sponsors
across recruiting studies
Top sites
Barcelona 9 Madrid 8 Seville 8 Lleida 3 Valencia 3
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona9 Madrid8 Seville8 Lleida3 Valencia3
All 25 locations
Target enrolment
to

Immunoglobulin A Nephropathy trials in Spain

10 of 5885 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
NCT07498335Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
28
Barcelona
2026-08-06
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
NCT07024563IgAN, IgAVN, Immunoglobulin A Nephropathy, Immunoglobulin A Vasculitis Associated Nephritis
Alexion Pharmaceuticals, Inc.
Phase 3
36
Almerรญa, Barcelona, Seville
2025-06-14
Active, closed
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142Immunoglobulin A Nephropathy
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Barcelona, Cรณrdoba, Lleida, Madrid, Pamplona, Santiago de Compostela, Seville, Valencia
2024-08-30
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
Alexion Pharmaceuticals, Inc.
Phase 3
579
A Coruรฑa, Alcalรก de Henares, Lleida, Madrid, Mรกlaga, Murcia, Oviedo, Seville
2024-03-29
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Manises, Barcelona, Girona, Lleida, Lugo, Madrid, Seville
2023-07-06
By invitation
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
NCT05248659Immunoglobulin A Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Barcelona, Cรณrdoba, Ellenboro, Madrid, Seville
2022-04-05
Active, closed
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT05248646Immunoglobulin A Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
A Coruรฑa, Barakaldo, Barcelona, Bilbao, Cรณrdoba, Ferrol, Madrid, Santander
2022-03-15
Recruiting
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
NCT05003986Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy, IgA Vasculitis
Travere Therapeutics, Inc.
Phase 2
67
Barcelona, Madrid, Seville
2021-08-12
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
404
Barcelona, Madrid, Sagunto, Seville, Valencia
2020-12-11
Active, closed
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
NCT03762850Immunoglobulin A Nephropathy
Travere Therapeutics, Inc.
Phase 3
406
Palma de Mallorca, Sagunto, Barcelona, Madrid, Seville, Valencia, Zaragoza
2018-12-11
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-spain/condition/immunoglobulin-a-nephropathy

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,885 studies in total at the last sync on 26 Sep 2026, 19:52 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Immunoglobulin A Nephropathy.

How many Immunoglobulin A Nephropathy trials are recruiting in Spain?

3 of the 10 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:52 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Immunoglobulin A Nephropathy), 10 studies
PhaseStudiesRecruitingShare
Phase 38280%
Phase 21110%
Phase 2/31010%

Most active sponsors

Lead sponsors with the most studies (Immunoglobulin A Nephropathy)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals31
Alexion Pharmaceuticals, Inc.21
Otsuka Pharmaceutical Development & Commercialization, Inc.20
Travere Therapeutics, Inc.21
Alpine Immune Sciences Inc, A Subsidiary of Vertex10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.